Loading...
Emerging Therapies in Immune Thrombocytopenia
Immune thrombocytopenia (ITP) is a rare autoimmune disorder caused by peripheral platelet destruction and inappropriate bone marrow production. The management of ITP is based on the utilization of steroids, intravenous immunoglobulins, rituximab, thrombopoietin receptor agonists (TPO-RAs), immunosup...
Saved in:
| Published in: | J Clin Med |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7958340/ https://ncbi.nlm.nih.gov/pubmed/33801294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10051004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|